These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 231533)

  • 1. Different sensitivites of cyclic nucleotide phosphodiesterases of rat brain and lung to inhibition by new anti-allergic chromones [proceedings].
    Saeed SA; Butt NM; Spicer JW; Warren BT
    Biochem Soc Trans; 1979 Dec; 7(6):1308-10. PubMed ID: 231533
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
    Butt NM; Saeed SA; Collier HO
    Biochem Soc Trans; 1980 Jun; 8(3):380-1. PubMed ID: 6249674
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds.
    Ruckstuhl M; Landry Y
    Biochem Pharmacol; 1981 Apr; 30(7):697-702. PubMed ID: 6264919
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonist.
    Chasin M; Scott C
    Biochem Pharmacol; 1978; 27(16):2065-7. PubMed ID: 214090
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects of cyclic nucleotides and their analogs and various agents on cyclic GMP-specific and cyclic AMP-specific phosphodiesterases purified from guinea pig lung.
    Davis CW; Kuo JF
    Biochem Pharmacol; 1978 Jan; 27(1):89-95. PubMed ID: 202285
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
    Glass WF; Moore JB
    Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
    [No Abstract]   [Full Text] [Related]  

  • 7. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
    Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I
    Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylxanthine inhibitors of phosphodiesterases.
    Wells JN; Miller JR
    Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on griseolic acid derivatives. I. Synthesis of substituted derivatives of griseolic acid at the N1, C6, C2' or C7' position and their biological activities.
    Kaneko M; Murofushi Y; Kimura M; Yamazaki M; Iijima Y
    Nucleic Acids Symp Ser; 1985; (16):89-92. PubMed ID: 3003711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors.
    Ruckstuhl M; Beretz A; Anton R; Landry Y
    Biochem Pharmacol; 1979; 28(4):535-8. PubMed ID: 218594
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds.
    Picq M; Dubois M; Prigent AF; Némoz G; Pacheco H
    Biochem Int; 1989 Jan; 18(1):47-57. PubMed ID: 2541724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human lymphocyte cyclic nucleotide phosphodiesterases by the chlorinated adenosine analog DTA-35.
    Hurwitz MY; Hurwitz RL; Edstrom RD
    J Enzyme Inhib; 1987; 1(4):267-74. PubMed ID: 2854846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat brain and lung cyclic nucleotide phosphodiesterases: different responses to cromoglycate [proceedings].
    Saeed SA; Butt NM; Taylor WA
    Biochem Soc Trans; 1979 Oct; 7(5):1037-8. PubMed ID: 229020
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of human lung cyclic nucleotide phosphodiesterases by proxyphylline, theophylline and their metabolites.
    Selvig K; Bjerve KS
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):250-2. PubMed ID: 6291318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
    Nemoz G; Prigent AF
    Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
    [No Abstract]   [Full Text] [Related]  

  • 17. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors.
    Walker KA; Boots MR; Stubbins JF; Rogers ME; Davis CW
    J Med Chem; 1983 Feb; 26(2):174-81. PubMed ID: 6298424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some pentasubstituted quercetin analogs.
    Picq M; Prigent AF; Nemoz G; Pacheco H
    Biochem Pharmacol; 1982 Sep; 31(17):2777-82. PubMed ID: 6291544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the inhibition of phosphodiesterase-catalyzed cyclic AMP and cyclic GMP breakdown and relaxation of canine tracheal smooth muscle.
    Polson JB; Krzanowski JJ; Fitzpatrick DF; Szentivanyi A
    Biochem Pharmacol; 1978 Jan; 27(2):254-6. PubMed ID: 203292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.